Form 8-K - Current report:
SEC Accession No. 0001628280-22-000460
Filing Date
2022-01-07
Accepted
2022-01-07 08:53:51
Documents
14
Period of Report
2022-01-07
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K absc-20220107.htm   iXBRL 8-K 37006
2 EX-99.1 exhibit991-8xkx22x01x07.htm EX-99.1 10297
6 absci_logo.jpg GRAPHIC 312098
  Complete submission text file 0001628280-22-000460.txt   598724

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT absc-20220107.xsd EX-101.SCH 1893
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT absc-20220107_lab.xml EX-101.LAB 24803
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT absc-20220107_pre.xml EX-101.PRE 13037
8 EXTRACTED XBRL INSTANCE DOCUMENT absc-20220107_htm.xml XML 11678
Mailing Address 18105 SE MILL PLAIN BLVD VANCOUVER WA 98683
Business Address 18105 SE MILL PLAIN BLVD VANCOUVER WA 98683 (360) 949-1041
Absci Corp (Filer) CIK: 0001672688 (see all company filings)

EIN.: 453931977 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40646 | Film No.: 22516589
SIC: 8731 Services-Commercial Physical & Biological Research